Bruker Announces Agreement to Acquire Neurescence Inc., Bolstering Neuroscience Research Portfolio
Delivers Simultaneous Multi-Region Neural Imaging of Free-Behaving Animals BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced the signing of the definitive agreement to purchase 100% of the shares of Neurescence Inc., an innovative provider of ultralight fiber-bundle Multiscopes™ for simultaneous multi-region, optical functional neuroimaging. Neurescence’s flagship product Chromatone™ moves illumination and detection hardware off... Read more